--- title: "ZYMERON CORPORATION — Capability Statement" uei: "GAMMMRQ6QMN1" cage: "7MVB7" canonical: "https://teamingindex.com/contractor/GAMMMRQ6QMN1/capability.md" html_url: "https://teamingindex.com/contractor/GAMMMRQ6QMN1" updated: "2026-11-09T17:28:18.052Z" generator: "TeamingIndex capability twin 1.0" legal_name: "ZYMERON CORPORATION" primary_naics: "541715" sam_status: "active" active_exclusion: false claimed: false tier: "unclaimed" --- # ZYMERON CORPORATION > ZYMERON CORPORATION is a SAM.gov-registered entity based in DURHAM, NC 27709. UEI GAMMMRQ6QMN1; CAGE 7MVB7; primary NAICS 541715. Compliance posture not provided. Active SAM registration. > **Unclaimed profile:** seeded from SAM.gov and USAspending public records. The entity has not claimed it, so capabilities and compliance posture have not been provided. ## Identifiers - **Legal business name:** ZYMERON CORPORATION - **UEI (SAM.gov Unique Entity ID):** GAMMMRQ6QMN1 - **CAGE code:** 7MVB7 - **Entity structure:** Corporate Entity (Not Tax Exempt) - **State of incorporation:** NC - **Website:** - **TeamingIndex profile:** - **Profile status:** Unclaimed · seeded from SAM.gov and USAspending public records ## Location - **Physical address (city, state, ZIP):** DURHAM, NC 27709 - **Country:** United States - **Congressional district:** NC-04 ## NAICS & PSC | NAICS | Title | Primary | Small under SBA size standard (SAM.gov) | | --- | --- | --- | --- | | 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Yes | No | | 541713 | Research and Development in Nanotechnology | No | Yes | | 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | No | Yes | - **PSC codes:** None on file Size status is NAICS-specific and reflects the entity’s SAM.gov representations; check it against the size standard of the solicitation’s NAICS code. ## Socio-economic status - Small Business (SB) Source: SAM.gov entity registration, synced 2026-11-09. Confirm current SBA certification (8(a), HUBZone, WOSB/EDWOSB, VetCert SDVOSB/VOSB) before relying on a status for a set-aside. ## SAM registration & exclusion screening - **Registration:** Active SAM registration - **Registration expires:** 2027-06-08 - **Registration activated:** 2026-06-10 - **Exclusion screening (FAR subpart 9.4):** No active exclusion recorded in SAM.gov - **Teaming eligibility:** Eligible to be proposed as a team member (active registration, no exclusion) - **Source:** SAM.gov Entity Management, synced 2026-11-09 ## Compliance posture Compliance posture not provided by the contractor. - Facility clearance: visible to paid members - Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). ## Contract vehicles No contract vehicle holdings on file. ## Past performance - **Total obligated, trailing 36 months (USAspending.gov):** $10,968,970 - **Award history:** 7 awards on record - **Top funding agencies:** Defense Health Agency; National Institutes of Health; Department of the Army Showing all 7 awards. | Award PIID | Agency | NAICS / PSC | Obligated | Base + all options | Period of performance | Set-aside | Place of performance | Description | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | HT942524C0057 | Department of Defense / Defense Health Agency | 541715 / AN12 | $2,999,983 | — | 2024-09-20 → 2027-07-19 | — | NC | DHA SBIR DIRECT PHASE II H2D-0243 RAPID SAMPLE PROCESSING DEVICE TO SUPPORT BATTLEFIELD WOUND INFECTION DIAGNOSTICS | | W81XWH22C0012 | Department of Defense / Defense Health Agency | 541715 / AN11 | $2,999,993 | — | 2022-02-07 → 2026-06-06 | — | NC | AWARD OF ZYMERON'S DHA SBIR PHASE II MEDICAL R&D CONTRACT FOR "DEVELOPMENT FOR A NOVEL COUNTERMEASURE, RADIODEFENDER, AS A RADIOPROTECTOR FOR HEMATOPOIETIC ACUTE RADIATION… | | HT942523C0067 | Department of Defense / Defense Health Agency | 541715 / AN12 | $2,999,999 | — | 2023-09-15 → 2026-01-14 | — | NC | DHA SBIR DIRECT TO PH II MEDICAL R&D CONTRACT AWARDED FROM PROPOSAL NO.-H2D-0119 FOR "DEVELOPMENT FOR SHOCKDEFENDER AGAINST HEMORRHAGIC SHOCK" | | HT942524P0034 | Department of Defense / Defense Health Agency | 541715 / AN11 | $249,995 | — | 2024-02-16 → 2024-09-15 | — | NC | DHA STTR PHASE 1 MEDICAL RESEARCH AND DEVELOPMENT PURCHASE ORDER FOR "PROPOSAL H23C-002-0028 "DEVELOPMENT OF WOUNDSHIELD FOR PSEUDOMONAS AERUGINOSA-CAUSED WOUNDS INFECTIONS" | | W911QY24P0008 | Department of Defense / Department of the Army | 541714 / AJ11 | $197,000 | — | 2023-12-14 → 2024-06-13 | — | NC | RESEARCH AND DEVELOPMENT | | 75N93021C00035 | Department of Health and Human Services / National Institutes of Health | 541714 / AN14 | $1,272,000 | — | 2021-08-12 → 2024-03-15 | — | NC | RAPID POINT OF CARE TESTS TO SIMULTANEOUSLY QUANTIFY ANTI-TB DRUGS IN BLOOD. | | HT942523P0041 | Department of Defense / Defense Health Agency | 541715 / AN11 | $250,000 | — | 2023-06-30 → 2024-01-29 | — | NC | ZYMERON DHA SBIR PHASE I H231-004-0023 NOVEL AEROSOL THERAPY FOR IMMEDIATE AND SUSTAINED ARDS MANAGEMENT | ## Proven teaming graph - No first-tier sub-award reports name this company yet - Source: USAspending.gov sub-award reports (FSRS), sync date not recorded. Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values. ## SBIR/STTR portfolio - SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects - 42 SBIR/STTR awards totaling $24.7M: SBIR Phase I 28, SBIR Phase II 8, STTR Phase I 5, STTR Phase II 1 - By agency: Department of Defense 22, Department of Health and Human Services 19, Department of Energy 1 - Active projects (contract end date ahead): 1 - Phase II awards ending within 12 months: 1 - SBIR Phase II (Direct to Phase II), Department of Defense (Defense Health Agency), 2024, Sep 12, 2024 to Jan 19, 2027: Rapid Sample Processing Device to Support Battlefield Wound Infection Diagnostics ($2,999,983) - STTR Phase I, Department of Defense (Defense Health Agency), 2024, Feb 13, 2024 to Sep 15, 2024: Development of WoundShield for Pseudomonas aeruginosa-Caused Wounds Infections ($249,995) - STTR Phase I, Department of Defense (Army), 2024, Dec 12, 2023 to Jun 13, 2024: Omnidetect: a multiplexed portable detection platform enables culture-free enrichment and amplification to detect all types of foodborne pathogens ($197,000) - STTR Phase I, Department of Defense (Defense Health Agency), 2024, Oct 5, 2023 to May 5, 2024: An Automated Blood-in, miRNAs-out Assay to Detect Circulating and Exosome miRNAs ($250,000) - SBIR Phase II (Direct to Phase II), Department of Defense (Defense Health Agency), 2023, Sep 14, 2023 to Jan 14, 2026: Development for ShockDefender against Hemorrhagic Shock ($2,999,999) - SBIR Phase I, Department of Energy, 2023, Jul 10, 2023 to Apr 9, 2024: Advanced portable low temperature plasma device for chronic wound disinfection and healing ($200,000) - SBIR Phase I, Department of Defense (Defense Health Agency), 2023, Jun 21, 2023 to Jan 29, 2024: Novel Aerosol Therapy for Immediate and Sustained ARDS Management ($250,000) - SBIR Phase I, Department of Health and Human Services (National Institutes of Health), 2023: RAPID POINT OF CARE TEST TO SCREEN HUMAN PAPILLOMAVIRUS IN LOW-RESOURCE SETTINGS ($13,720) - SBIR Phase II, Department of Defense (Defense Advanced Research Projects Agency), 2022, Aug 26, 2022 to Aug 26, 2025: Lab-on-Chip Microfiltering and Imaging Device for Rapid and Automated Sterility Testing ($1,491,568) - SBIR Phase II, Department of Defense (Defense Health Agency), 2022, Jul 6, 2022 to Nov 10, 2024: Novel Antibiotics Targeting Multidrug-Resistant Pseudomonas Aeruginosa Infections ($1,100,000) - Phase III: Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual. - Source: SBIR.gov award data file, as of Nov 12, 2026 (file published Nov 1, 2026) ## FedRAMP offerings - No FedRAMP Marketplace listing is linked to this company - Source: FedRAMP Marketplace, sync date not recorded ## Exclusions & screening - Not yet checked against SAM.gov exclusions (search exclusions on SAM.gov: https://sam.gov/search/?index=ex) - Source: SAM.gov Exclusions, sync date not recorded - No confirmed match on the Consolidated Screening List (screened Nov 13, 2026) ## Contract vehicles on federal record - No contract-vehicle seats on federal record are linked to this company ## GSA CALC+ rates - No GSA CALC+ awarded ceiling rates on record for this company - Source: GSA CALC+ awarded ceiling rates, sync date not recorded. Ceiling rates are the most an agency can be charged, not prices paid ## Capabilities & differentiators No capability narrative published. ## Technical tags No technical tags published. ## Teaming preferences - Teaming preferences not published - **Teaming requests and NDAs:** request an introduction on the TeamingIndex profile (sign-in required): ## Business development contact No business-development contact published. ## Corporate hierarchy - No parent entity reported in SAM.gov - Affiliation with a parent or sister concerns can affect small-business size status (13 CFR 121.103). ## Provenance & disclaimer - **SAM.gov entity registration** (identifiers, NAICS/PSC, size and socio-economic status, hierarchy, registration and exclusion status): synced 2026-11-09 - **USAspending.gov** (prime award history and trailing 36-month obligations): nightly sync - **Contractor-provided profile** (capabilities, teaming preferences, self-attested compliance): not provided - **TeamingIndex verification** (credentials marked “Verified by TeamingIndex”): no verified credentials on record; methodology: - **Blind SPRS:** exact NIST SP 800-171 SPRS scores are published only when the contractor opts in; brackets are cumulative thresholds (SPRS ≥ 0, SPRS ≥ 50, SPRS ≥ 70, SPRS ≥ 85, SPRS ≥ 95, SPRS ≥ 105, SPRS = 110 (perfect)). - **Before award:** self-attested facts have not been independently verified. Confirm registration and exclusions in SAM.gov, CMMC status and SPRS assessment currency with the contractor (DFARS 252.204-7019, -7020 and -7021), facility clearances through DCSA’s NISS, AS9100-series certificates in the IAQG OASIS database, and FedRAMP authorizations on the FedRAMP Marketplace. - **Zero CUI:** this document contains no Controlled Unclassified Information. TeamingIndex stores verification metadata only, never SSPs, POA&Ms or DD Form 254s. - **Machine-readable:** schema.org JSON-LD is embedded in ; this twin: ; site index: © 2026 HILARTECH, LLC. All rights reserved. TeamingIndex.com is an independent defense industrial base intelligence platform owned and operated by HILARTECH, LLC and is not affiliated with or endorsed by the U.S. Department of Defense (DoD), the General Services Administration (GSA), or SAM.gov.